Your browser doesn't support javascript.
loading
Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers.
Ma, Yuze; Gao, Feng.
Affiliation
  • Ma Y; Research Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Gao F; Research Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. rggaofeng@sdu.edu.cn.
Cancer Imaging ; 24(1): 19, 2024 Jan 26.
Article in En | MEDLINE | ID: mdl-38279185
ABSTRACT
GRPR is a type of seven-transmembrane G-protein coupled receptor that belongs to the bombesin protein receptor family. It is highly expressed in various cancers, including prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and so on. As a result, molecular imaging studies have been conducted using radiolabeled GRPR ligands for tumor diagnosis, as well as monitoring of recurrence and metastasis. In this paper, we provided a comprehensive overview of relevant literature from the past two decades, with a specific focus on the advancements made in radiolabeled GRPR ligands for imaging prostate cancer and breast cancer.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms Limits: Humans / Male Language: En Journal: Cancer Imaging Journal subject: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms Limits: Humans / Male Language: En Journal: Cancer Imaging Journal subject: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido